Specifically, the study revealed that the vaccination of FAPα-expressing B16F10 melanoma cells led to a significant retardation in tumor growth and an enhancement in survival rates of C57BL/6J mice in the experimental group, as compared to the control groups in both experimental studies. This evidence concerns the gene FAP and neoplasm.